Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$406M |
| 2 |
Baidu
BIDU
|
+$382M |
| 3 |
AGN
Allergan plc
AGN
|
+$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$312M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
+$370M |
| 3 |
Pfizer
PFE
|
+$343M |
| 4 |
Gilead Sciences
GILD
|
+$331M |
| 5 |
Amazon
AMZN
|
+$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Ring Energy
REI
$211M
| $259K | ﹤0.01% |
392,633
+301,033
| +329% | +$199K |
|
|
BCYC
3027
Bicycle Therapeutics
BCYC
$487M
| $257K | ﹤0.01% |
+18,800
| New | +$257K |
|
|
DYNT
3028
DELISTED
Dynatronics Corp
DYNT
| $257K | ﹤0.01% |
59,440
+49,420
| +493% | +$214K |
|
|
ELOX
3029
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $256K | ﹤0.01% |
3,270
-143
| -4% | -$11.2K |
|
|
VNE
3030
DELISTED
Veoneer, Inc.
VNE
| $256K | ﹤0.01% |
+35,000
| New | +$256K |
|
3031
Better Online Solutions
BOSC
$30.3M
| $254K | ﹤0.01% |
142,615
+1,211
| +0.9% | +$2.16K |
|
3032
Veritex Holdings
VBTX
$1.88B
| $254K | ﹤0.01% |
+18,172
| New | +$254K |
|
3033
CareCloud
CCLD
$160M
| $253K | ﹤0.01% |
46,033
+20,833
| +83% | +$114K |
|
3034
Schwab US Mid-Cap ETF
SCHM
$12.4B
| $253K | ﹤0.01% |
18,000
-15,753
| -47% | -$221K |
|
3035
iShares Russell 2000 ETF
IWM
$67.6B
| $249K | ﹤0.01% |
+2,174
| New | +$249K |
|
3036
iShares National Muni Bond ETF
MUB
$39.5B
| $249K | ﹤0.01% |
2,200
-116,900
| -98% | -$13.2M |
|
|
WHWK
3037
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$94.7M
| $248K | ﹤0.01% |
30,109
+2,967
| +11% | +$24.4K |
|
|
DSLV
3038
DELISTED
VelocitySharesTM 3x Inverse Silver ETN linked to the S&P GSCI Silver Inverse Index ER
DSLV
| $248K | ﹤0.01% |
+10,482
| New | +$248K |
|
3039
Illumina
ILMN
$15.3B
| $246K | ﹤0.01% |
+925
| New | +$246K |
|
3040
Palisade Bio
PALI
$5.42M
| $246K | ﹤0.01% |
83
+25
| +43% | +$74.1K |
|
3041
Taylor Devices
TAYD
$150M
| $246K | ﹤0.01% |
29,135
+3,035
| +12% | +$25.6K |
|
|
NYMX
3042
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $245K | ﹤0.01% |
104,700
+69,019
| +193% | +$162K |
|
3043
Pegasystems
PEGA
$9.94B
| $244K | ﹤0.01% |
+6,848
| New | +$244K |
|
3044
Duluth Holdings
DLTH
$133M
| $243K | ﹤0.01% |
+60,500
| New | +$243K |
|
|
IMMP
3045
Immutep
IMMP
$244M
| $243K | ﹤0.01% |
337,289
+238,968
| +243% | +$172K |
|
3046
Amplify Energy
AMPY
$161M
| $242K | ﹤0.01% |
+427,800
| New | +$242K |
|
3047
iShares Global Energy ETF
IXC
$1.85B
| $242K | ﹤0.01% |
+14,300
| New | +$242K |
|
3048
Limbach Holdings
LMB
$1.2B
| $242K | ﹤0.01% |
84,917
-37,800
| -31% | -$108K |
|
|
FLNT
3049
Fluent
FLNT
$49.3M
| $241K | ﹤0.01% |
34,318
-4,166
| -11% | -$29.3K |
|
|
ICON
3050
DELISTED
Iconix Brand Group, Inc.
ICON
| $240K | ﹤0.01% |
361,678
+5,300
| +1% | +$3.52K |
|